ARCH Venture Partners X, LLC - 10%+ Owner at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: 10%+ Owner
Issuer Symbol: NMRA on Nasdaq
All Insider Reports: All Insider Reports

ARCH Venture Partners X, LLC - trading volume in the past year for Neumora Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+1,915,700	100%	$2.61	+$4,999,977
Sells
Net	+1,915,700	100%		+$4,999,977

Holdings reported by ARCH Venture Partners X, LLC for Neumora Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	12,205,379	$22,213,789	$1.82	27 Oct 2025	By ARCH Venture Fund X, L.P.
Common Stock	11,886,758	$21,633,899	$1.82	27 Oct 2025	By ARCH Venture Fund X Overage, L.P.
Common Stock	6,046,907	$15,782,427	$2.61	27 Oct 2025	By ARCH Venture Fund XII, L.P.
Common Stock	2,321,566	$4,225,250	$1.82	27 Oct 2025	By ARCH Venture Fund VIII Overage, L.P.
Common Stock	1,387,228	$2,524,754	$1.82	27 Oct 2025	By ARCH Venture Fund VII, L.P.

Transactions reported by ARCH Venture Partners X, LLC for Neumora Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.